Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on November 26, 2001

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet.

PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]
 
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing *
00P-1322 Food Labeling and Allergen Contamination Control *
01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA *
01N-0397 Transportation Safety & Potentially Sedating or Impairing *
01N-0400 Safety & Effectiveness of New Drug & Biological Products in *
01N-0423 Substances Prohibited from use in animal food/Feed Ruminant *
01P-0471 Issue the NFR Placement of Anthrax Vaccine as Category II *
77N-0085 Saccharin and Its Salts

CA 17283 Donat J. Gladue Vol#: 395

CA 17845 R. P. Ferguson Vol#: 402

CA 17878 Frank Kirwin Vol#: 402

80N-0042 Anticaries Drug Products for OTC Human Use

EXT 11 CHPA & CTFA Vol#: 36

00D-1543 Electronic Signatures: Glossary of Terms

C 2 J. Edward Crosson, Jr. Vol#: 5

00D-1557 Indwelling Blood Gas Analyzer 510(k)

GDL 2 Guideline Vol#: 1

00D-1558 Electrical Safety, Electromagnetic Capatibility & Mech Test

GDL 2 Guideline Vol#: 1

00N-1571 Enrofloxacin for Poultry: Opportunity for hearing

M 2 GCF-1 Vol#: 25

00P-1322 Food Labeling and Allergen Contamination Control

C 484 Kimberley Johnson Scott Vol#: 29

01D-0475 Providing Regulatory Submissions in Electronic Format-ANDA's

GDL 1 GUIDANCE Vol#: 1

NAD 1 Vol#: 1

01M-0522 PMA VISX Star Excimer Laser System, Models S2 & S3 P930016/S

AAV 1 ViSX, Inc Vol#: 1

01M-0523 GYNECARE INTERGEL Adhesion Prevention Solution, P990015

AAV 1 Lifecore Biomedical Inc Vol#: 1

01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA

SUP 1 American Home Products Corporation Vol#: 1

01N-0256 Use of Opiate Analgesics in Various Patient Population inclu

C 322 Patrick Mcgrath, Jr. Vol#: 8

01N-0397 Transportation Safety & Potentially Sedating or Impairing

TS 5 National Transportation Safety Board Vol#: 2

TS 6 HF-1, FDA Commissioner Vol#: 2

TS 7 Consumer Healthcare Products Association Vol#: 2

TS 8 PhRMA Vol#: 2

TS 9 Georgetown University School of Medicine Vol#: 2

TS 10 Consumer Healthcare Products Association Vol#: 2

TS 11 PhRMA Vol#: 2

TS 12 Utrecht University, NL Vol#: 2

TS 13 University of Maastricht Vol#: 2

TS 14 National Institute of Forensic, Norway Vol#: 2

TS 15 Office of the Chief Medical Examiner, DC Vol#: 2

01N-0400 Safety & Effectiveness of New Drug & Biological Products in

C 1 Merck & Co, Inc. Vol#: 1

01N-0423 Substances Prohibited from use in animal food/Feed Ruminant

CH 17 Y-U Cattlel Company Vol#: 5

CH 18 Darling International Inc. Vol#: 5

CH 19 APPMA Vol#: 5

CH 20 Pet Food Institute Vol#: 5

TR 1 Transcript of meeting 10/30/01 Vol#: 6

01P-0471 Issue the NFR Placement of Anthrax Vaccine as Category II

C 1 Paula Vol#: 1

C 2 T. J. Donnelly Vol#: 1

01V-0527 Variance for Q-Beam Series Q-40(RG)(MC), Q-150, Q175, Q500 (

ACK 1 HFA-305 Vol#: 1

VAR 1 CJ&J Consulting DBA: NV at Strand Vol#: 1

01V-0528 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 Cherry Optical Holography Vol#: 1